UNLIMITED TURBO SHORT - MEDTRONIC Share Price

Certificat

DE000PH43844

Delayed Deutsche Boerse AG 03:51:05 19/06/2024 pm IST
4.15 EUR -0.48% Intraday chart for UNLIMITED TURBO SHORT - MEDTRONIC
Current month+3.73%
1 month+17.46%
Date Price Change
19/24/19 4.15 -0.48%
18/24/18 4.17 -0.48%
17/24/17 4.19 +2.44%
14/24/14 4.09 +2.25%
13/24/13 4 +2.04%

Delayed Quote Deutsche Boerse AG

Last update June 19, 2024 at 03:51 pm IST

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellPUT
Underlying MEDTRONIC PLC
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PH4384
ISINDE000PH43844
Date issued 15/09/2021
Strike 124 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.43
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 5.28
Lowest since issue 0.21
Spread 0.11
Spread %2.58%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
79.75 USD
Average target price
94.07 USD
Spread / Average Target
+17.95%
Consensus